JPRN-jRCT1040220016Completed未知
Cross sectional study to investigate the difference in needs between patients and health care providers for systemic therapy of renal cell carcinoma
Hiromi Kitano0 sites83 target enrollmentStarted: May 3, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 83
Study Overview
Brief Summary
This study demonstrated a gap between patients with mRCC and physicians in their expectations and concerns for systemic therapy. Japanese patients with mRCC suffer from a number of adverse events, some of which are not shared with physicians. This study highlights the importance of communicating well with patients in clinical practice to achieve patient-centricity in systemic treatment for mRCC.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •- Agreed web questionnaire survey.
- •- 20 year and older.
- •- Live in Japan.
- •- Received or ongoing molecular targeted therapy or immune checkpoint inhibitor (including combination therapy) for renal cell carcinoma.
- •- Agreed web questionnaire survey.
- •- Doctors, nurses, or pharmacists who are engaged in systemic therapy of renal cell carcinoma.
Exclusion Criteria
- •- Have families engaged in pharmatheutical/survey/marketing company or health care.
- •- Have double cancer.
- •- Doctors, nurses, or pharmacists who are not engaged in systemic therapy of renal cell carcinoma.
Investigators
Similar Trials
Terminated
Not Applicable
Physician-Patient Communication and Expectations Regarding Ovarian Cancer PrognosisOvarian CancerNCT02769546Abramson Cancer Center at Penn Medicine50
Completed
Not Applicable
A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.Carcinoma, Renal CellClear-cell Metastatic Renal Cell CarcinomaNCT05745142Pfizer376
Completed
Not Applicable
Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC PatientsComplete Remission in Renal Cell CarcinomaNCT01934452Pfizer77
Completed
Not Applicable
Quality of Life in IPF - Patient and Physician PerceptionsIdiopathic Pulmonary FibrosisNCT04148157University of Washington100
Completed
Not Applicable
Patient Questionnaire Research on Perceived Differences in Usability and Sensation between New and Old Formulations of the Bisono TapeJPRN-UMIN000037469Japan Medical Research Institute CO.,LTD.104